Supreme Court Rejects Merck’s Bid to Reinstate $2.5B Damage Award Against Rival January 20, 2021 By Andrew Chung The U.S. Supreme Court on Tuesday rejected Merck & Co. Inc.’s bid to revive a $2.54 billion jury verdict it...
Merck Loses Bid to Collect Patent Infringement Damages from Gilead April 26, 2018 By Jan Wolfe A U.S. appeals court on Wednesday affirmed a ruling that pharmaceutical company Merck & Co. dishonestly obtained patent rights and...
Insurers Balk at High Cost of Specialty Drug May 21, 2014 The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines,...